Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myeloma

被引:0
|
作者
M Ladetto
S Ferrero
D Drandi
M Festuccia
F Patriarca
N Mordini
S Cena
R Benedetto
G Guarona
F Ferrando
L Brunello
P Ghione
V Boccasavia
R Fanin
P Omedè
L Giaccone
A Palumbo
R Passera
M Boccadoro
B Bruno
机构
[1] A.O.U. Città della Salute e della Scienza di Torino,Division of Hematology
[2] University of Torino,Department of Molecular Biotechnology and Health Sciences
[3] University of Torino,Division of Hematology
[4] Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo,Division of Hematology
[5] A.O.U,Division of Nuclear Medicine
[6] Udine,undefined
[7] DISM,undefined
[8] University of Udine,undefined
[9] Ospedale ‘S.Croce e Carle’,undefined
[10] Statistical Consultant,undefined
[11] A.O.U. Città della Salute e della Scienza di Torino,undefined
来源
Leukemia | 2016年 / 30卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1211 / 1214
页数:3
相关论文
共 50 条
  • [41] Evaluation of the Prognostic Value of the Mayo Additive Staging System and Minimal Residual Disease in Newly Diagnosed Multiple Myeloma Patients
    Song, Yichuan
    Zhao, Rui
    Fu, Wenxuan
    Zhao, Jing
    Wang, Qingtao
    Zhang, Rui
    CANCER MEDICINE, 2024, 13 (21):
  • [42] Tumour markers for monitoring minimal residual disease in multiple myeloma.
    Rothwell, DG
    Kalakonda, N
    Norton, JD
    Hawkins, RE
    Chopra, R
    BLOOD, 2000, 96 (11) : 151A - 151A
  • [43] Minimal Residual Disease Monitoring During Maintenance In Multiple Myeloma Patients
    Rocci, Alberto
    Gambella, Manuela
    Omede, Paola
    Drandi, Daniela
    Gay, Francesca
    Patriarca, Francesca
    Cavallo, Federica
    Petrucci, Maria Teresa
    Tommaso, Caravita
    Benevolo, Giulia
    Pescosta, Norbert
    Oliva, Stefania
    Offidani, Massimo
    Montefusco, Vittorio
    Liberati, Anna Marina
    Falcone, Antonietta Pia
    Ballanati, Stelvio
    Spadano, Tonino
    Guglielmelli, Tommasina
    Musto, Pellegrino
    Zarnbello, Renato
    Di Raimondo, Francesco
    Ladetto, Marco
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2013, 122 (21)
  • [44] Durable responses after donor lymphocyte infusion for patients with residual multiple myeloma following non-myeloablative allogeneic stem cell transplant
    Beitinjaneh, Amer M.
    Saliba, Rima
    Bashir, Qaiser
    Shah, Nina
    Parmar, Simrit
    Hosing, Chitara
    Popat, Uday
    Anderlini, Paolo
    Dinh, Yvonne
    Qureshi, Sofia
    Rondon, Gabriela
    Champlin, Richard E.
    Giralt, Sergio A.
    Qazilbash, Muzaffar H.
    LEUKEMIA & LYMPHOMA, 2012, 53 (08) : 1525 - 1529
  • [45] Significant graft-vs-myeloma (GvM) effect after non-myeloablative allogeneic transplantation in multiple myeloma (MM).
    Badros, A
    Tricot, G
    Morris, C
    Fox, M
    Munshi, N
    Spoon, D
    Martin, S
    Toor, A
    Zangari, M
    Fassas, A
    Desikan, R
    Anaissie, E
    Barlogie, B
    BLOOD, 2000, 96 (11) : 352B - 352B
  • [46] Patterns of minimal residual disease after high dose therapy in myeloma - A comparison of allografting and autografting.
    Haynes, AP
    Carter, GI
    Owen, R
    Davis, F
    Byrne, J
    Bybee, A
    Samsom, D
    Morgan, GJ
    Russell, NH
    BLOOD, 1997, 90 (10) : 995 - 995
  • [47] Evaluation of Molecular Minimal Residual Disease in Multiple Myeloma: An Institutional Experience
    Hanley, Tim
    Clement, Parker
    Dickey, Laura
    Li, K. David
    MODERN PATHOLOGY, 2018, 31 : 519 - 520
  • [48] Evaluation of Molecular Minimal Residual Disease in Multiple Myeloma: An Institutional Experience
    Hanley, Tim
    Clement, Parker
    Dickey, Laura
    Li, K. David
    LABORATORY INVESTIGATION, 2018, 98 : 519 - 520
  • [49] High Rates of Prolonged Molecular Remissions After Tandem Autologous-Nonmyeloablative Allografting in Newly Diagnosed Myeloma
    Ladetto, Marco
    Ferrero, Simone
    Drandi, Daniela
    Omede, Paola
    Patriarca, Francesca
    Mordini, Nicola
    Cena, Silvia
    Barbero, Daniela
    Monitillo, Luigia
    Giaccone, Luisa
    Rocci, Alberto
    Barbiero, Sara
    Festuccia, Moreno
    Gallamini, Andrea
    Fanin, Renato
    Passera, Roberto
    Palumbo, Antonio
    Boccadoro, Mario
    Bruno, Benedetto
    BLOOD, 2012, 120 (21)
  • [50] HIGH RATES OF PROLONGED MOLECULAR REMISSIONS AFTER TANDEM AUTOLOGOUS-NONMYELOABLATIVE ALLOGRAFTING IN NEWLY DIAGNOSED MYELOMA
    Ladetto, M.
    Ferrero, S.
    Drandi, D.
    Omede, P.
    Festuccia, M.
    Patriarca, F.
    Mordini, N.
    Cena, S.
    Monitillo, L.
    Giaccone, L.
    Barbero, Daniela
    Rocci, Alberto
    Barbiero, Sara
    Gallamini, Andrea
    Fanin, Renato
    Passera, Roberto
    Palumbo, A.
    Boccadoro, M.
    Bruno, B.
    HAEMATOLOGICA, 2013, 98 : 320 - 320